Sarah E. Gibson, MD
Assistant Professor of Pathology

Dr. Gibson is a member of the Division of Hematopathology.

Office Location:
Suite G300
Rm. G-314 UPMC Presbyterian
200 Lothrop Street
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-647-4162
Fax: 412-647-0374

Clinical Expertise


Research Expertise

Hematopoietic and lymphoid disorders; molecular hematopathology

Selected Publications

View Dr. Gibson's publications on PubMed

Bieliauskas S, Tubbs RR, Bacon C, Eshoa C, Foucar K, Gibson SE, Kroft S, Sohani A, Swerdlow SH, Cook JR. Gamma heavy chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases. Am J Surg Pathol. 2012;36:534-43.

Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris NL, Hasserjian RP. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica. 2011;96:1144-52.

Gibson SE, Swerdlow SH, Craig FE, Surti U, Cook JR, Nalesnik MA, Lowe C, Wood KM, Bacon CM. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the post-transplant setting: a distinct type of post-transplant lymphoproliferative disorder? Am J Surg Pathol. 2011;35:807-15.

Advani AS, Gibson S, Douglas E, Diacovo J, Elson P, Kalaycio M, Copelan E, Sekeres M, Sobecks R, Sungren S, Lagoo A, Rizzieri D, Hsi E. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukemia (ALL). Br J Haematol. 2011;153:504-7.

Gibson SE, Swerdlow SH, Felgar RE. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features. Hum Pathol. 2011;42:679-87.

Advani AS, Gibson SE, Douglas E, Jin T, Zhao X, Kalaycio M, Copelan E, Sobecks R, Sekeres M, Sungren S, Hsi ED. Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients. BMC Cancer. 2010;10:387.

Advani AS, Lim K, Gibson S, Shadman M, Jin T, Copelan E, Kalaycio M, Sekeres MA, Sobecks R, Hsi E. OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma. 2010;51:606-12.

Nasir S, Klimczak A, Sonmez E, Bozkurt M, Gibson S, Siemionow M. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap. Transpl Int. 2010;23:90-100.